APOTHEEK TWEE NETEN
ActiveFrom the official registers: KBO 28 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
APOTHEEK TWEE NETEN has been active since 1997 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €734,464 and a net result of €49,100. Equity has been growing by about 11% per year since 2019. Its solvency ranks better than 95% of 12,757 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Official details
KBO- Status
- Active since 20-11-1997 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730
- Establishment units
- 2.086.231.854 2500 Lier, since 02-04-1998
- 2.388.209.284 2500 Lier, since 02-03-2026
- Financial year end
- 30 June
- Peppol
- Reachable
Board and ownership
- STEANN PHARMADirector · permanent representative Anneleen DE SWERT
- Holdings
- Shares in 1 company APOTHEEK TWEE NETEN
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
- Gross margin
- €253,310
- ▲ 13.9%
- Turnover
- ≈ €920,000
- estimated
- Profit
- €49,100
- ▼ 25.6%
- Equity
- €734,464
- ▲ 7.2%
- Total assets
- €819,103
- ▲ 2.8%
- Staff
- 2.3 FTE
- =
Score breakdownraises riskSector: Retail trade (NACE 47)lowers riskEquity €734,464 (89.7% of total assets)Liquidity: current ratio 7.16, cash €117,561Founded in 1997Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 92% of them on solvency, 74% on liquidity, 64% on profitability and 56% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 16 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
Comparable companies
These companies have the same main activity as APOTHEEK TWEE NETEN: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €701,000 and €924,000, founded between 1995 and 1999.
| Company | Total assets | Gross margin |
|---|---|---|
| APOTHEEK TWEE NETEN Lier | €819,103 | €253,310 |
| SANTE SERVICES Mons | €829,810 | €251,051 |
| APOTHEEK DECLERCK Kortrijk | €790,903 | €278,652 |
| APOTHEEK MEES SPALBEEK Hasselt | €913,234 | €243,881 |
| APOTHEEK CURAVIT Kalmthout | €700,757 | €254,159 |
| Apotheek Desrumaux Mortsel | €924,163 | €290,968 |
| APOTHEEK HEALTHCORNER Berlaar | €825,767 | €321,313 |
Documents
Annual accounts at the NBB
- Annual accounts 2025filed on 19-01-2026
- Annual accounts 2024filed on 04-02-2025
- Annual accounts 2023filed on 29-01-2024
- Annual accounts 2022filed on 13-12-2022
Acts in the Belgian Official Gazette
- Purpose · Amendment of the articles · Name · Restructuringact of 31-03-2026
- Restructuringact of 26-01-2026
- Purpose · Amendment of the articles · Legal-form change · Resignations & appointmentsact of 12-01-2024
Articles and registers
- Coordinated articles of associationnotaries' database
- Entry in the KBO registerKBO Public Search
Key facts about APOTHEEK TWEE NETEN
- What is the company number of APOTHEEK TWEE NETEN?
- The company number of APOTHEEK TWEE NETEN is 0461.936.764. The VAT number is the same number with BE in front: BE 0461.936.764.
- Where is APOTHEEK TWEE NETEN based?
- The registered office is at Berlarij 10, 2500 Lier.Company details
- What does APOTHEEK TWEE NETEN do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of APOTHEEK TWEE NETEN?
- The legal form of APOTHEEK TWEE NETEN is Private limited company (BV).
- When was APOTHEEK TWEE NETEN founded?
- APOTHEEK TWEE NETEN was founded on 20-11-1997.
- Is APOTHEEK TWEE NETEN still active?
- Yes, APOTHEEK TWEE NETEN is an active enterprise in the KBO register.
- How many employees does APOTHEEK TWEE NETEN have?
- APOTHEEK TWEE NETEN had an average of 2.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of APOTHEEK TWEE NETEN?
- The turnover in financial year 2025 is ≈ €920,000. This figure is estimated from the gross margin of €253,310 and 47 comparable companies (NACE 477). It probably lies between €720,000 and €1.5m.
- Is APOTHEEK TWEE NETEN profitable?
- In financial year 2025, APOTHEEK TWEE NETEN made a profit of €49,100.
- Where can I find the annual accounts of APOTHEEK TWEE NETEN?
- APOTHEEK TWEE NETEN filed 28 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
- When are the next annual accounts of APOTHEEK TWEE NETEN due?
- APOTHEEK TWEE NETEN must file the annual accounts for financial year 2026 by 31-01-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.